Prediction of the 70-gene signature (MammaPrint) high versus low risk by nomograms among axillary lymph node positive (LN+) and negative (LN-) Chinese breast cancer patients, a retrospective study

Related articles

1. The Value of LAR in Predicting Neoadjuvant Therapy Response and Prognosis in HER-2-Positive Breast Cancer

   This article has 5 authors:

   1. Xiaojing Li
   2. Xin Xin
   3. Wenjing Xiong
   4. Haoyue zhang
   5. Yue Zhang

2. Prognostic Analysis of Neoadjuvant versus Adjuvant Chemotherapy for Stage III Rectal Cancer with Tumor Deposit-Positive Via the SEER Database

   This article has 5 authors:

   1. Fengjiao Wu
   2. Yuanhui Tian
   3. Qian Han
   4. Peng Liu
   5. Ke Li

3. A Nomogram Combining Clinical, Metabolic, and Serum Markers to Predict the Risk of Primary Breast Lymphoma Recurrence

   This article has 3 authors:

   1. Tianyi Zhou
   2. Guobao Chen
   3. Shuo Zhou